EMEA-002893- PIP01-20-M01
Table of contents
Key facts
| Invented name |
|
| Active substance |
mRNA that encodes for the pre-fusion stabilized spike glycoprotein of SARS-CoV-2 (mRNA-1273)
|
| Therapeutic area |
|
| Decision number |
P/0444/2021
|
| PIP number |
EMEA-002893- PIP01-20-M01
|
| Pharmaceutical form(s) |
Dispersion for injection
|
| Condition(s) / indication(s) |
Prevention of Coronavirus disease 2019 (COVID-19)
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
MODERNA BIOTECH SPAIN, S.L.
E-mail: Nadia.Assenova@modernatx.com Tel. +41 794746697 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|